1-4 of 4
Niklas Gebauer
Close
Sort by
Journal Articles

Mutational Changes in Solid Cancer Cells Induce DNA Damage Repair Deficiency in Hematopoietic Cells Leading to a Distinct Spectrum of Clonal Hematopoiesis Independent from Age-Related Clonal Hematopoiesis

Theo Leitner, Axel Künstner, Michael Kohl, Tobias Barmwater, Helal Mohammed Ahmed, Almuth Caliebe, Eva Dazert-Klebsattel, Anke Fähnrich, Stephanie Fliedner, Niklas Gebauer, Malte Spielmann, Jutta Kirfel, Verena-Wilbeth Sailer, Lorenz Bastian, Nikolas Von Bubnoff, Hauke Busch, Cyrus Khandanpour
Journal: Blood
Blood (2023) 142 (Supplement 1): 5605.
https://doi.org/10.1182/blood-2023-184994
Published: 2023
Journal Articles

Genome-Wide DNA Methylation Profiling in Blastic Plasmacytoid Dendritic Cell Neoplasm

Hanno M. Witte, Axel Künstner, Julian Schwarting, Veronica Bernard, Stephanie Stölting, Nikolas von Bubnoff, Eva Penas, Hartmut Merz, Reiner Siebert, Hauke Busch, Alfred Feller, Niklas Gebauer
Journal: Blood
Blood (2022) 140 (Supplement 1): 11496–11497.
https://doi.org/10.1182/blood-2022-162212
Published: 2022
Journal Articles

Polatuzumab Vedotin in Relapsed and Refractory (r/r) Large B-Cell Lymphoma (LBCL): Real-World Data of the German National Compassionate Use Program (CUP)

Nora Liebers, MD, Johannes Duell, MD, Daniel Nörenberg, MD, Eva Kaebisch, MD, Andrea Kerkhoff, MD, Fabian Acker, MD, Stephan Fuhrmann, MD, Corinna Leng, MD PhD, Manfred Welslau, MD, Jens Chemnitz, MD, Jan Moritz Middeke, MD, Thomas Weber, MD, Ralf Ulrich Trappe, MD, Roald Pfannes, MD, Ruediger Liersch, MD, Christian Spoer, MD, Niklas Gebauer, MD, Stefan Fuxius, MD, Léandra Caillé, Christiane Pott, MD PhD, Christian Koenecke, MD, Udo Holtick, Thomas Geer, MD, Ulrich Keller, MD, Rainer Claus, MD, Dimitrios Mougiakakos, MD, Stephanie Mayer, MD, Andreas Hüttmann, MD, Arne Trummer, MD, Gerald Wulf, MD, Uta Brunnberg, MD, Lars Bullinger, MD, Georg Hess, MD, Carsten Mueller-Tidow, MD, Bertram Glass, MD, Georg Lenz, Peter Dreger, MD, Sascha Dietrich, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 11–13.
https://doi.org/10.1182/blood-2020-136539
Published: 2020
Journal Articles

The Integrated Glasgow Prognostic- and Cytogenetic Risk Score (CytoGPS) at Diagnosis Is a Strong and Independent Predictor of Survival in Transplant-Eligible Patients with Multiple Myelom

Hanno Maximilian Witte, MD, Harald Biersack, MD, Armin Riecke, MD, Bastian Bonorden, MD, Svenja Kopelke, MD, Hartmut Merz, Prof. Dr., Veronica Bernard, MD, Hendrik Lehnert, Prof. Dr., Miriam Kull, MD, Sebastian Fetscher, MD, Niklas Gebauer, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4509.
https://doi.org/10.1182/blood-2018-99-117361
Published: 2018